1. Home
  2. IVVD vs III Comparison

IVVD vs III Comparison

Compare IVVD & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.61

Market Cap

212.6M

Sector

Health Care

ML Signal

HOLD

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$6.18

Market Cap

197.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
III
Founded
2020
2006
Country
United States
United States
Employees
N/A
1500
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
212.6M
197.1M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
IVVD
III
Price
$0.61
$6.18
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
★ $10.00
$6.80
AVG Volume (30 Days)
★ 4.7M
212.6K
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
★ 2.98%
EPS Growth
79.02
★ 216.67
EPS
N/A
★ 0.12
Revenue
$53,426,000.00
★ $192,745,000.00
Revenue This Year
$12.40
$4.24
Revenue Next Year
$44.85
$3.59
P/E Ratio
★ N/A
$50.75
Revenue Growth
★ 110.47
4.51
52 Week Low
$0.53
$3.74
52 Week High
$3.07
$6.45

Technical Indicators

Market Signals
Indicator
IVVD
III
Relative Strength Index (RSI) 37.25 72.91
Support Level $0.53 $3.86
Resistance Level $1.02 N/A
Average True Range (ATR) 0.06 0.19
MACD -0.01 0.01
Stochastic Oscillator 5.55 88.89

Price Performance

Historical Comparison
IVVD
III

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

Share on Social Networks: